UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancer

Journal of the Formosan Medical Association, 2023-01, Vol.122 (1), p.4-8

2023

Volltextzugriff (PDF)

Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives

Journal of the Formosan Medical Association, 2020-02, Vol.119 (2), p.565-568

2020

Volltextzugriff (PDF)

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Liver cancer (Basel ), 2019-11, Vol.8 (6), p.480-490

2019

Volltextzugriff (PDF)

Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer

World journal of gastroenterology : WJG, 2016-08, Vol.22 (32), p.7275-7288

2016

Volltextzugriff (PDF)

B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

Frontiers in oncology, 2022-06, Vol.12, p.879398-879398

2022

Volltextzugriff (PDF)

Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma

Esophagus : official journal of the Japan Esophageal Society, 2022-10, Vol.19 (4), p.693-701

2022

Volltextzugriff (PDF)

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy

PloS one, 2017-07, Vol.12 (7), p.e0180628-e0180628

2017

Volltextzugriff (PDF)

Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer

Journal of gastroenterology and hepatology, 2016-12, Vol.31 (12), p.2004-2012

2016

Volltextzugriff (PDF)

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Thoracic cancer, 2023-08, Vol.14 (22), p.2216-2221

2023

Volltextzugriff (PDF)

Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients

Journal of the Formosan Medical Association, 2020-01, Vol.119 (1), p.97-105

2020

Volltextzugriff (PDF)

Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma

Urological science, 2019-01, Vol.30 (1), p.2-7

2019

Volltextzugriff (PDF)

Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study

International journal of clinical oncology, 2014-08, Vol.19 (4), p.634-642

2014

Volltextzugriff (PDF)

Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

Anticancer research, 2019-10, Vol.39 (10), p.5675-5682

2019

Volltextzugriff (PDF)

A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Clinical cancer research, 2022-12, Vol.28 (23), p.5058-5065

2022

Volltextzugriff (PDF)

Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy

Journal of cancer research and clinical oncology, 2022-07, Vol.148 (7), p.1803-1811

2022

Volltextzugriff (PDF)

Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites

Oncology, 2021-09, Vol.99 (10), p.652-658

2021

Volltextzugriff (PDF)

Rational combination with an immunotherapy backbone in genitourinary cancers

Urological science, 2020-01, Vol.31 (1), p.4-7

2020

Volltextzugriff (PDF)

Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma

Journal of thoracic oncology, 2018-03, Vol.13 (3), p.e36-e39

2018

Volltextzugriff (PDF)

Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy

Anticancer research, 2018-03, Vol.38 (3), p.1569-1577

2018

Volltextzugriff (PDF)

Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer

Journal of clinical medicine, 2019-07, Vol.8 (8), p.1115

2019

Volltextzugriff (PDF)

Radiotherapy as salvage treatment after failure of tyrosine kinase inhibitors for a patient with advanced gastrointestinal stromal tumor

Journal of cancer research and practice, 2018-12, Vol.5 (4), p.156-160

2018

Volltextzugriff (PDF)

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Journal of thoracic oncology, 2015-10, Vol.10 (10), p.1481-1489

2015

Volltextzugriff (PDF)

Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis

Medical oncology (Northwood, London, England), 2017-08, Vol.34 (8), p.143-143, Article 143

2017

Volltextzugriff (PDF)

Immune-related Giant Cell Myocarditis after Immune Checkpoint Inhibitor Therapy in a Patient with Urothelial Carcinoma and Myasthenia Gravis

Journal of cancer research and practice, 2023-01, Vol.10 (1), p.31-33

2023

Volltextzugriff (PDF)

Digital versus manual pathology scoring of PD-L1 in patients with esophageal squamous cell carcinoma (ESCC)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.e16023-e16023

2024

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(55)
Mit Volltextzugriff
(48)

Publikationsform

Artikel
(56)
Berichte
(1)

Sprache

Englisch
(57)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Embracing anti-PD-1 immunotherapy in the treatment of esophageal cancer: Implications of positive phase III trials in advanced and resected esophageal cancer

Anti-PD-1 immunotherapy in advanced esophageal squamous cell carcinoma: A long-awaited breakthrough finally arrives

Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Perspectives on the combination of radiotherapy and targeted therapy with DNA repair inhibitors in the treatment of pancreatic cancer

B Cells in Tumor Microenvironment Associated With The Clinical Benefit to Programmed Cell Death Protein-1 Blockade Therapy in Patients With Advanced Esophageal Squamous Cell Carcinoma

Deleterious alterations of DNA damage response and repair genes and clinical benefit to anti-PD-1 therapy in esophageal squamous cell carcinoma

Association of MDM2 expression with shorter progression-free survival and overall survival in patients with advanced pancreatic cancer treated with gemcitabine-based chemotherapy

Association of radiotherapy with favorable prognosis in daily clinical practice for treatment of locally advanced and metastatic pancreatic cancer

Different immune contextures underlie tumor site‐specific responses to immune checkpoint blockade in esophageal cancer

Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients

Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma

Sequential gemcitabine and platinum versus first-line combination of gemcitabine and platinum for advanced pancreatic cancer treatment: a retrospective study

Neutrophil–to–lymphocyte Ratio and Use of Antibiotics Associated With Prognosis in Esophageal Squamous Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors

A Single-Arm Phase Ib/II Study of Lenvatinib plus Eribulin in Advanced Liposarcoma and Leiomyosarcoma

Prognostic value of PD-L1 expression on immune cells or tumor cells for locally advanced esophageal squamous cell carcinoma in patients treated with neoadjuvant chemoradiotherapy

Response to Immune Checkpoint Inhibitors in Recurrent or Metastatic Esophageal Squamous Cell Carcinoma May Be Affected by Tumor Sites

Rational combination with an immunotherapy backbone in genitourinary cancers

Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma

Number of Resected Lymph Nodes and Survival of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Preoperative Chemoradiotherapy

Postoperative Imaging and Tumor Marker Surveillance in Resected Pancreatic Cancer

Radiotherapy as salvage treatment after failure of tyrosine kinase inhibitors for a patient with advanced gastrointestinal stromal tumor

Postchemoradiotherapy Pathologic Stage Classified by the American Joint Committee on the Cancer Staging System Predicts Prognosis of Patients with Locally Advanced Esophageal Squamous Cell Carcinoma

Computed tomographic characteristics for patients with unresectable gastric cancer harboring low-volume peritoneal carcinomatosis

Immune-related Giant Cell Myocarditis after Immune Checkpoint Inhibitor Therapy in a Patient with Urothelial Carcinoma and Myasthenia Gravis

Digital versus manual pathology scoring of PD-L1 in patients with esophageal squamous cell carcinoma (ESCC)

Suchergebnisse filtern